US Secures 300 Million Doses of Potential AstraZeneca Covid-19 Vaccine
Team Udayavani, May 22, 2020, 1:26 PM IST
AstraZeneca has received more than $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority to develop a coronavirus vaccine from the University of Oxford
The United States has secured almost a third of the first one billion doses planned for AstraZeneca’s experimental Covid-19 vaccine
Alex Azar, U.S. Health Secretary said, “This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,”
The vaccine, previously known as ChAdOx1 nCoV-19 and now as AZD1222, was developed by the University of Oxford and licensed to AstraZeneca. The first doses of AZD1222 are expected to be delivered in October.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
China says talks on Tibet only with Dalai Lama’s representatives; rules out dialogue on autonomy
Indian-origin man shot, killed by San Antonio police amid attempts to apprehend him
2 Indian restaurants in Colorado duped investors of USD 380K: Officials
WATCH: 5 runaway military horses cause mayhem in London
Don’t blame Dubai’s freak rain on cloud seeding
MUST WATCH
Latest Additions
Patanjali Foods to evaluate proposal to buy Patanjali Ayurved’s non-food business
Congress to discuss candidates for Amethi, Raebareli seats on Saturday
BJP’s CT Ravi Booked for Promoting Hatred and Enmity Through Social Media Post
Elections held in 14 LS segments in Karnataka, voter turnout nearly 64 per cent till 5 pm
‘PM is scared, may even shed tears on stage’: Rahul Gandhi’s fresh salvo at Modi